- Home
- ECO vs MDXG Comparison
ECO vs MDXG Comparison
Compare ECO & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ECO | MDXG |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ECO | MDXG |
|---|---|---|
| Price | $39.04 | $5.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $37.00 | $11.00 |
| AVG Volume (30 Days) | 318.3K | ★ 898.5K |
| Earning Date | 02-18-2026 | 02-25-2026 |
| Dividend Yield | ★ 5.25% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.38 | 0.27 |
| Revenue | $349,886,578.00 | ★ $393,442,000.00 |
| Revenue This Year | N/A | $19.13 |
| Revenue Next Year | $5.10 | $2.11 |
| P/E Ratio | ★ $18.83 | $21.07 |
| Revenue Growth | N/A | ★ 14.77 |
| 52 Week Low | $17.91 | $5.55 |
| 52 Week High | $41.31 | $9.36 |
Technical Indicators
Market Signals| Indicator | ECO | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 62.60 | 26.90 |
| Support Level | $31.75 | $5.55 |
| Resistance Level | $41.31 | $6.50 |
| Average True Range (ATR) | 1.10 | 0.22 |
| MACD | 0.73 | -0.10 |
| Stochastic Oscillator | 76.34 | 13.61 |
Price Performance
Historical ComparisonAbout ECO Okeanis Eco Tankers Corp.
Okeanis Eco Tankers Corp owns and operates tanker vessels in Greece. The business of the company is to own, charter out, and operate tanker vessels. The company owns, through its vessel-owning subsidiaries, a fleet of around seven tanker vessels and has around eight tanker vessels on order. The sailing fleet consists of around six modern Suezmax tankers and eight VLCC tankers.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.